CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/18/2022
Back to search
Official data from USPTO
THESEUS PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THESEUS PHARMACEUTICALS
ST13
US500000087795766Class
42
Filing
87795766
Registration
6719056
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
05/18/2022
Trademark type
Word
Nice classes
42
Filing date
02/13/2018
Registration date
05/03/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/03/2022
Last transaction
05/03/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/29/2017
First use in commerce
04/18/2021
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
ROSEN, BENJAMIN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc.
Representatives
Jessica L. Rothstein GOODWIN PROCTER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and biomedical researchdevelopmenttesting of pharmaceuticals and preparations for the treatmentdiagnosisprophylaxis of cancer and other diseases; development of pharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
56 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/18/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/03/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/29/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/28/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/05/2022
IUAF
USE AMENDMENT FILED
03/04/2022
EISU
TEAS STATEMENT OF USE RECEIVED
03/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/09/2021
EX5G
SOU EXTENSION 5 GRANTED
09/08/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/03/2021
EXT5
SOU EXTENSION 5 FILED
08/31/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/31/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/27/2021
EX4G
SOU EXTENSION 4 GRANTED
02/25/2021
EXT4
SOU EXTENSION 4 FILED
02/25/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/25/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/03/2020
EX3G
SOU EXTENSION 3 GRANTED
09/01/2020
EXT3
SOU EXTENSION 3 FILED
09/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/05/2020
EX2G
SOU EXTENSION 2 GRANTED
03/03/2020
EXT2
SOU EXTENSION 2 FILED
03/03/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/03/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/03/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/02/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/14/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/06/2019
EX1G
SOU EXTENSION 1 GRANTED
09/04/2019
EXT1
SOU EXTENSION 1 FILED
09/04/2019
EEXT
SOU TEAS EXTENSION RECEIVED
09/04/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/08/2019
PUBO
PUBLISHED FOR OPPOSITION
01/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
11/28/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/28/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
11/28/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/28/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2018
ALIE
ASSIGNED TO LIE
10/26/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/07/2018
GNRT
NON-FINAL ACTION E-MAILED
06/07/2018
CNRT
NON-FINAL ACTION WRITTEN
06/07/2018
DOCK
ASSIGNED TO EXAMINER
05/29/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/21/2018
NWAP
NEW APPLICATION ENTERED
02/16/2018
Continuous trademark protection
Get notified about every new filing that threatens THESEUS PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.